Provided by Tiger Trade Technology Pte. Ltd.

INmune Bio Inc

1.96
+0.01000.51%
Volume:243.59K
Turnover:470.01K
Market Cap:54.40M
PE:-2.83
High:1.97
Open:1.97
Low:1.89
Close:1.95
52wk High:2.60
52wk Low:1.09
Shares:27.75M
Float Shares:23.19M
Volume Ratio:1.62
T/O Rate:1.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6937
EPS(LYR):-1.8600
ROE:-74.82%
ROA:-39.12%
PB:2.67
PE(LYR):-1.05

Loading ...

Inmune Bio Completes Commercial Manufacturing Milestone Supporting Planned Global Registration Filings for Cordstrom™ Platform

THOMSON REUTERS
·
Jul 20

INmune Bio Completes Commercial Manufacturing Milestone Supporting Planned Global Registration Filings for CORDStrom™ Platform

GlobeNewswire
·
Jul 20

INmune Bio Says Study Shows Drug Candidate Reduced Alzheimer's-Related Brain Changes After Brain Injury

MT Newswires Live
·
Jul 15

Inmune Bio - Cordstrom to File Maa with UK Mhra and EU Ema in 2026; U.S. Bla Planned

THOMSON REUTERS
·
Jul 15

Inmune Bio - Xpro1595 Selectively Neutralizes Soluble Tnf

THOMSON REUTERS
·
Jul 15

Inmune Bio’s Xpro1595 Prevents Brain-injury-induced Alzheimer's Pathology, Memory Loss, and Pain in New Peer-reviewed Preclinical Study

THOMSON REUTERS
·
Jul 15

INmune Bio And 2 Other Promising Penny Stocks To Consider

Simply Wall St.
·
Jul 14

Inmune Bio Says Phase 2 Xpro Trial Shows Significant Week 24 MRI Myelin Benefit in Early Alzheimer’s Patients

Reuters
·
Jul 09

Sector Update: Healthcare Stocks Edge Higher Premarket Wednesday

MT Newswires Live
·
Jul 01

INmune Bio Files US Patent Application for CORDStrom Cell Therapy Platform

MT Newswires Live
·
Jul 01

INmune Bio advances CORDStrom platform patent application in the U.S.

TIPRANKS
·
Jul 01

Inmune Bio Says Holders Exercise 647,112 Warrants at $1.4 Per Share Under Inducement Offer

Reuters
·
Jul 01

INmune Bio Advances CORDStrom™ Platform Patent Application in the U.S. Following Favorable International Written Opinion

GlobeNewswire
·
Jul 01

Inmune Bio Wins MHRA Pediatric Plan Approval for Ebstrocel in RDEB

Reuters
·
Jun 25

Inmune Bio Inc. Achieves Mhra Approval of Pip for Cordstrom™

THOMSON REUTERS
·
Jun 25

Inmune Bio - UK Mhra Approves Pediatric Investigation Plan for Ebstrocel for Rdeb

THOMSON REUTERS
·
Jun 25

Inmune Bio - Preparing for Maa Submission and Final Manufacturing for Ebstrocel

THOMSON REUTERS
·
Jun 25

INmune Bio Inc. Achieves MHRA Approval of PIP for CORDStrom™

GlobeNewswire
·
Jun 25

Analysts Are Bullish on These Healthcare Stocks: Inmune Bio (INMB), AbSci (ABSI)

TIPRANKS
·
Jun 25

INmune Bio announces MHRA alignment in pre-MAA CORDStrom meeting

TIPRANKS
·
Jun 24